PXMD
Income statement / Annual
Last year (2023), PaxMedica, Inc. Common Stock's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, PaxMedica, Inc. Common Stock's net income was -$18.29 M.
See PaxMedica, Inc. Common Stock,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$3.92 M
|
$1.79 M
|
$2.23 M
|
$936.78 K
|
$484.11 K
|
| General & Administrative Expenses |
$12.23 B
|
$8.82 M
|
$4.97 M
|
$4.63 M
|
$114.50 K
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$12.23 M
|
$8.82 M
|
$4.97 M
|
$4.63 M
|
$114.50 K
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$224.00
|
$0.00
|
| Operating Expenses |
$16.15 M
|
$10.60 M
|
$7.20 M
|
$5.57 M
|
$598.61 K
|
| Cost And Expenses |
$16.15 M
|
$10.60 M
|
$7.20 M
|
$5.57 M
|
$598.61 K
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$9.17 K
|
$5.24 K
|
$2.81 M
|
$609.46 K
|
$0.00
|
| Depreciation & Amortization |
$2.14 M
|
$0.00
|
$173.35 K
|
$0.00
|
$0.00
|
| EBITDA |
-$16.15 M |
-$16.51 M |
-$7.20 M |
-$5.62 M |
-$599.00 K |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$2.14 M
|
-$4.20 M
|
-$3.03 M
|
-$2.26 M
|
$0.00
|
| Income Before Tax |
-$18.29 M
|
-$14.80 M
|
-$10.23 M
|
-$7.83 M
|
-$599.00 K
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$4.19 M
|
$2.81 M
|
$663.00 K
|
$0.00
|
| Net Income |
-$18.29 M
|
-$14.80 M
|
-$13.04 M
|
-$8.49 M
|
-$599.00 K
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
| EPS |
-11 |
-28.73 |
-18.81 |
-13.42 |
-0.0598 |
| EPS Diluted |
-11 |
-28.73 |
-18.81 |
-13.42 |
-0.0598 |
| Weighted Average Shares Out |
$1.66 M
|
$514.22 K
|
$692.91 K
|
$589.20 K
|
$589.20 K
|
| Weighted Average Shares Out Diluted |
$1.66 M
|
$514.22 K
|
$692.91 K
|
$589.20 K
|
$589.20 K
|
| Link |
|
|
|
|
|
